Children's Hospital of Philadelphia
Thank you for visiting CHOP vectors at ASGCT!
• More than 50 active clinical trials
• More than 80 investigators engaged in basic and translational research
• 20+ unique clinical and pre-clinical programs
• A leader in providing 11 licensed cell and gene therapies
• Treated more than 120 patients from 15 countries with in vivo gene therapies
• Bench to bedside-enabling infrastructure, from vector manufacturing to navigating FDA regulatory process to clinical trials
Brands: For Clinical Vector Core inquiries: Dr. Van der loo at: VANDERLOOJ@chop.edu.
For Research Vector Core inquiries: Xueyuan Liu at: LIUXU@chop.edu.